Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LONDON, ON--(Marketwired - March 11, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company") reported its financial and operating...
-
TRURO, NOVA SCOTIA--(Marketwired - March 11, 2016) - CUPE locals whose members are affected by the McNeil Government's Bill 148 will gather in Truro tomorrow, March 12, 2016, for a...
-
SAN FRANCISCO, CA--(Marketwired - Mar 11, 2016) - TokBox, a Telefónica company, today announced it will unveil its WebRTC powered Telehealth Solution at the SXSW Interactive SX Health &...
-
Progenics Pharmaceuticals Announces Fourth Quarter and Full-Year 2015 Financial and Business Results
RELISTOR® Net Sales Increased to $23.0 Million for the Fourth Quarter Oral RELISTOR Remains On-track for April 19, 2016 PDUFASubcutaneous RELISTOR Approved in Europe for All Opioid-Induced...
-
EDMONTON, AB--(Marketwired - March 11, 2016) - Annual Highlights Rental Revenue of $65.48 million for growth of 47% over 2014. Net rental income of $39.87 million for growth...
-
VERNAL, Utah, March 11, 2016 (GLOBE NEWSWIRE) -- Superior Drilling Products, Inc. (NYSE MKT:SDPI) (“SDP” or the “Company”), a provider of drilling products for the oil, natural gas and mining...
-
Notice is hereby given to the shareholders of Meda AB (publ), corp.reg.no 556427 -2812, that the Annual General Meeting (AGM) will be held at 5.00 PM on Thursday, April 14, 2016, at Meda’s...
-
Helsinki, Suomi, 2016-03-11 09:32 CET (GLOBE NEWSWIRE) -- CORRECTION TO PLC UUTECHNIC GROUP OYJ’S STOCK EXCHANGE RELEASE PUBLISHED ON MARCH 11, 2016 AT 9:30 AM WRONG COMPANY NAME (VAAHTO) IN THE...
-
Helsinki, Finland, 2016-03-11 08:30 CET (GLOBE NEWSWIRE) -- REVIEW OF PLC UUTECHIC GROUP OYJ’S FINANCIAL STATEMENTS 11 MARCH, 2016 AT 09:30 am REVIEW OF UUTECHNIC GROUP’S FINANCIAL STATEMENTS FOR...
-
Sanofi and Regeneron Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis Paris, France and...